These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35172473)

  • 21. Restriction site associated DNA sequencing for tumour mutation burden estimation and mutation signature analysis.
    McGuinness CF; Black MA; Dunbier AK
    Cancer Med; 2023 Dec; 12(23):21545-21560. PubMed ID: 37974533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma.
    Zhang L; Zhou Y; Cheng C; Cui H; Cheng L; Kong P; Wang J; Li Y; Chen W; Song B; Wang F; Jia Z; Li L; Li Y; Yang B; Liu J; Shi R; Bi Y; Zhang Y; Wang J; Zhao Z; Hu X; Yang J; Li H; Gao Z; Chen G; Huang X; Yang X; Wan S; Chen C; Li B; Tan Y; Chen L; He M; Xie S; Li X; Zhuang X; Wang M; Xia Z; Luo L; Ma J; Dong B; Zhao J; Song Y; Ou Y; Li E; Xu L; Wang J; Xi Y; Li G; Xu E; Liang J; Yang X; Guo J; Chen X; Zhang Y; Li Q; Liu L; Li Y; Zhang X; Yang H; Lin D; Cheng X; Guo Y; Wang J; Zhan Q; Cui Y
    Am J Hum Genet; 2015 Apr; 96(4):597-611. PubMed ID: 25839328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutational processes molding the genomes of 21 breast cancers.
    Nik-Zainal S; Alexandrov LB; Wedge DC; Van Loo P; Greenman CD; Raine K; Jones D; Hinton J; Marshall J; Stebbings LA; Menzies A; Martin S; Leung K; Chen L; Leroy C; Ramakrishna M; Rance R; Lau KW; Mudie LJ; Varela I; McBride DJ; Bignell GR; Cooke SL; Shlien A; Gamble J; Whitmore I; Maddison M; Tarpey PS; Davies HR; Papaemmanuil E; Stephens PJ; McLaren S; Butler AP; Teague JW; Jönsson G; Garber JE; Silver D; Miron P; Fatima A; Boyault S; Langerød A; Tutt A; Martens JW; Aparicio SA; Borg Å; Salomon AV; Thomas G; Børresen-Dale AL; Richardson AL; Neuberger MS; Futreal PA; Campbell PJ; Stratton MR;
    Cell; 2012 May; 149(5):979-93. PubMed ID: 22608084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling clinical and molecular covariates of mutational process activity in cancer.
    Robinson W; Sharan R; Leiserson MDM
    Bioinformatics; 2019 Jul; 35(14):i492-i500. PubMed ID: 31510643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signatures of mutational processes in human cancer.
    Alexandrov LB; Nik-Zainal S; Wedge DC; Aparicio SA; Behjati S; Biankin AV; Bignell GR; Bolli N; Borg A; Børresen-Dale AL; Boyault S; Burkhardt B; Butler AP; Caldas C; Davies HR; Desmedt C; Eils R; Eyfjörd JE; Foekens JA; Greaves M; Hosoda F; Hutter B; Ilicic T; Imbeaud S; Imielinski M; Jäger N; Jones DT; Jones D; Knappskog S; Kool M; Lakhani SR; López-Otín C; Martin S; Munshi NC; Nakamura H; Northcott PA; Pajic M; Papaemmanuil E; Paradiso A; Pearson JV; Puente XS; Raine K; Ramakrishna M; Richardson AL; Richter J; Rosenstiel P; Schlesner M; Schumacher TN; Span PN; Teague JW; Totoki Y; Tutt AN; Valdés-Mas R; van Buuren MM; van 't Veer L; Vincent-Salomon A; Waddell N; Yates LR; ; ; ; ; Zucman-Rossi J; Futreal PA; McDermott U; Lichter P; Meyerson M; Grimmond SM; Siebert R; Campo E; Shibata T; Pfister SM; Campbell PJ; Stratton MR
    Nature; 2013 Aug; 500(7463):415-21. PubMed ID: 23945592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AID expression in B-cell lymphomas causes accumulation of genomic uracil and a distinct AID mutational signature.
    Pettersen HS; Galashevskaya A; Doseth B; Sousa MM; Sarno A; Visnes T; Aas PA; Liabakk NB; Slupphaug G; Sætrom P; Kavli B; Krokan HE
    DNA Repair (Amst); 2015 Jan; 25():60-71. PubMed ID: 25486549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A framework for mutational signature analysis based on DNA shape parameters.
    Karolak A; Levatić J; Supek F
    PLoS One; 2022; 17(1):e0262495. PubMed ID: 35015788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clustered Mutation Signatures Reveal that Error-Prone DNA Repair Targets Mutations to Active Genes.
    Supek F; Lehner B
    Cell; 2017 Jul; 170(3):534-547.e23. PubMed ID: 28753428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA Repair Footprint Uncovers Contribution of DNA Repair Mechanism to Mutational Signatures.
    Wojtowicz D; Leiserson MDM; Sharan R; Przytycka TM
    Pac Symp Biocomput; 2020; 25():262-273. PubMed ID: 31797602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative genomic analysis identifies associations of molecular alterations to APOBEC and BRCA1/2 mutational signatures in breast cancer.
    Trevino V
    Mol Genet Genomic Med; 2019 Aug; 7(8):e810. PubMed ID: 31294536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy
    Denkert C; Untch M; Benz S; Schneeweiss A; Weber KE; Schmatloch S; Jackisch C; Sinn HP; Golovato J; Karn T; Marmé F; Link T; Budczies J; Nekljudova V; Schmitt WD; Stickeler E; Müller V; Jank P; Parulkar R; Heinmöller E; Sanborn JZ; Schem C; Sinn BV; Soon-Shiong P; van Mackelenbergh M; Fasching PA; Rabizadeh S; Loibl S
    Ann Oncol; 2021 Apr; 32(4):500-511. PubMed ID: 33418062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MutationalPatterns: the one stop shop for the analysis of mutational processes.
    Manders F; Brandsma AM; de Kanter J; Verheul M; Oka R; van Roosmalen MJ; van der Roest B; van Hoeck A; Cuppen E; van Boxtel R
    BMC Genomics; 2022 Feb; 23(1):134. PubMed ID: 35168570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immune response-related mutational signatures and driver genes in non-small-cell lung cancer.
    Chen H; Chong W; Teng C; Yao Y; Wang X; Li X
    Cancer Sci; 2019 Aug; 110(8):2348-2356. PubMed ID: 31222843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clock-like accumulation of germline and somatic mutations can arise from the interplay of DNA damage and repair.
    Spisak N; de Manuel M; Milligan W; Sella G; Przeworski M
    PLoS Biol; 2024 Jun; 22(6):e3002678. PubMed ID: 38885262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation Signatures Depend on Epigenomic Contexts.
    Coleman N; De S
    Trends Cancer; 2018 Oct; 4(10):659-661. PubMed ID: 30292349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatic hypermutation in immunity and cancer: Critical analysis of strand-biased and codon-context mutation signatures.
    Steele EJ
    DNA Repair (Amst); 2016 Sep; 45():1-24. PubMed ID: 27449479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A data-driven approach for constructing mutation categories for mutational signature analysis.
    Gilad G; Leiserson MDM; Sharan R
    PLoS Comput Biol; 2021 Oct; 17(10):e1009542. PubMed ID: 34665813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional mutational signature activities in cancer genomes.
    Timmons C; Morris Q; Harrigan CF
    PLoS Comput Biol; 2022 Dec; 18(12):e1010733. PubMed ID: 36469539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational signatures of redox stress in yeast single-strand DNA and of aging in human mitochondrial DNA share a common feature.
    Degtyareva NP; Saini N; Sterling JF; Placentra VC; Klimczak LJ; Gordenin DA; Doetsch PW
    PLoS Biol; 2019 May; 17(5):e3000263. PubMed ID: 31067233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AID/APOBEC deaminases and cancer.
    Rebhandl S; Huemer M; Greil R; Geisberger R
    Oncoscience; 2015; 2(4):320-33. PubMed ID: 26097867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.